TY - JOUR
T1 - Molecular diagnosis of orbital inflammatory disease
AU - The Orbital Disease Consortium
AU - Rosenbaum, James T.
AU - Choi, Dongseok
AU - Wilson, David J.
AU - Grossniklaus, Hans E.
AU - Sibley, Cailin H.
AU - Harrington, Christina A.
AU - Planck, Stephen R.
N1 - Funding Information:
Financial support was from NIH Grants EY020249 , EY010572 and RR024140 , the Research to Prevent Blindness , the William and Mary Bauman Foundation , the Mas Family Foundation , and the Stan and Madelle Rosenfeld Family Trust .
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Orbital inflammatory diseases include thyroid eye disease (TED), granulomatosis with polyangiitis (GPA), sarcoidosis, and nonspecific orbital inflammation (NSOI). Histopathological diagnosis usually relies on the clinical context and is not always definitive. Gene expression profiling provides diagnostic and therapeutic information in several malignancies, but its role in evaluating nonmalignant disease is relatively untested. We hypothesized that gene expression profiling could provide diagnostic information for NSOI. We collected formalin-fixed, paraffin-embedded orbital biopsies from 10 institutions and 83 subjects including 25 with thyroid eye disease, 25 nonspecific orbital inflammation, 20 healthy controls, 6 with granulomatosis with polyangiitis, and 7 with sarcoidosis. Tissues were divided into discovery and validation sets. Gene expression was quantified using Affymetrix U133 Plus 2.0 microarrays. A random forest statistical algorithm based on data from 39 probe sets identified controls, GPA, or TED with an average accuracy of 76% (p. = 0.02). Random forest analysis indicated that 52% of tissues from patients with nonspecific inflammation were consistent with a diagnosis of GPA. Molecular diagnosis by gene expression profiling will augment clinical data and histopathology in differentiating forms of orbital inflammatory disease.
AB - Orbital inflammatory diseases include thyroid eye disease (TED), granulomatosis with polyangiitis (GPA), sarcoidosis, and nonspecific orbital inflammation (NSOI). Histopathological diagnosis usually relies on the clinical context and is not always definitive. Gene expression profiling provides diagnostic and therapeutic information in several malignancies, but its role in evaluating nonmalignant disease is relatively untested. We hypothesized that gene expression profiling could provide diagnostic information for NSOI. We collected formalin-fixed, paraffin-embedded orbital biopsies from 10 institutions and 83 subjects including 25 with thyroid eye disease, 25 nonspecific orbital inflammation, 20 healthy controls, 6 with granulomatosis with polyangiitis, and 7 with sarcoidosis. Tissues were divided into discovery and validation sets. Gene expression was quantified using Affymetrix U133 Plus 2.0 microarrays. A random forest statistical algorithm based on data from 39 probe sets identified controls, GPA, or TED with an average accuracy of 76% (p. = 0.02). Random forest analysis indicated that 52% of tissues from patients with nonspecific inflammation were consistent with a diagnosis of GPA. Molecular diagnosis by gene expression profiling will augment clinical data and histopathology in differentiating forms of orbital inflammatory disease.
KW - Gene expression
KW - Granulomatosis with polyangiitis
KW - Orbital inflammation
KW - Sarcoidosis
KW - Thyroid eye disease
UR - http://www.scopus.com/inward/record.url?scp=84924621523&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924621523&partnerID=8YFLogxK
U2 - 10.1016/j.yexmp.2015.01.009
DO - 10.1016/j.yexmp.2015.01.009
M3 - Article
C2 - 25595914
AN - SCOPUS:84924621523
SN - 0014-4800
VL - 98
SP - 225
EP - 229
JO - Experimental and Molecular Pathology
JF - Experimental and Molecular Pathology
IS - 2
ER -